News Center

Jan 12, 2018

Washington, DC – In their continuing inquiry into skyrocketing costs for insulin, Diabetes Caucus co-chairs Rep. Diana DeGette (D-CO) and Rep. Tom Reed (R-NY) today sent five more letters to health care industry stakeholders seeking further information about health plan benefit design and drug discount programs offered by pharmaceutical companies.

Nov 9, 2017

Washington, DC – The co-chairs of the Congressional Diabetes Caucus, Rep. Diana DeGette (D-CO) and Rep. Tom Reed (R-NY), have released a bipartisan request for stakeholders to provide information about whether health plans can pay for insulin based on how well the particular drug product works for patients.

Oct 11, 2017

Washington, D.C.- Reps. Tom Reed (R-NY) and Diana DeGette (D-CO), co-chairs of the Congressional Diabetes Caucus, commend the House passage today of the National Clinical Care Commission Act.

Sep 21, 2017

Washington, DC – The co-chairs of the Congressional Diabetes Caucus, Reps. Diana DeGette (D-CO) and Tom Reed (R-NY), are taking next steps in their inquiry into the rising price of insulin after meetings during the past two months with stakeholders at major trade associations and in the diabetes community.

Apr 4, 2014
As you begin the appropriations process for Fiscal year(FY) 2015, the undersigned Members of Congress ask that you give strong consideration to the burden of diabetes in the United States and provide $20 million for the National Diabetes Prevention Program (NDPP) at the Centers for Disease Control and Prevention (CDC).
Oct 22, 2013
We write to ask for your continued support for the Special Diabetes Program (SDP), which is imporving the lives of 26 million Americans who have diabetes and yielding a real return on the federal investment.
May 29, 2013
As the chairs and vice-chairs of the Congressional Diabetes Caucus, we would like to present the April edition of the Caucus Quarterly Newsletter.
Oct 26, 2012
We thought you may be interested in the attached Congressional Research Service (CRS) recently released report on the Federal Activities and Spending for Diabetes Prevention, Research, and Treatment.
Oct 26, 2012
To support congressional work on diabetes-related activities CRS has prepared this memorandum providing details of the federal government’s involvement in and spending on diabetes mellitus research, surveillance, prevention and education, and health treatment.
Apr 26, 2012
We write to ask for your continued support of the Special Diabetes Program as we work in a bipartisan manner on its reauthorization. The Special Diabetes Program is demonstrating real returns on the federal investment it has received and is creatiing a brighter future for Americans burdened by diabetes.